RAMM Pharma Corp
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$1.19M
-0.07
$2.56M
RAMM Pharma Corp. engages in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-11-08. The company has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The firm also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The firm owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The firm's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
RAMM Pharma Corp. engages in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-11-08. The company has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The firm also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The firm owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The firm's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.